Jüngste Beiträge
- My Experience with Mazdutide Injection for Weight Control: Shedding Pounds and Gaining Confidence with DengYueMedHey everyone, I'm Sarah, a 35-year-old mom of two who's been on a rollercoaster with my weight for years. Like many of you, I've tried everything from fad diets to intense workout regimes, but nothing stuck long-term. That all changed when I discovered Mazdutide injection for weight control. I want to share my personal experience in hopes it might help someone else out there who's struggling....0 Kommentare 0 Anteile 797 AnsichtenPlease log in to like, share and comment!
- Recombinant Human Albumin Injection (Oryza Sativa): A New Hope for Hypoalbuminemia in CirrhosisIn the realm of modern medicine, cirrhosis remains a prevalent chronic liver disease, often accompanied by hypoalbuminemia (serum albumin levels ≤30 g/L), leading to complications such as ascites and edema that severely impact patients' quality of life. Traditional treatments rely on albumin derived from human plasma, but supply is limited, and there's a potential risk of blood-borne...0 Kommentare 0 Anteile 1124 Ansichten
- Blinatumomab (BLINCYTO) Prescribing Information | Hong Kong Dengyue MedicineBLINCYTO® is the world’s first approved BiTE® immuno-oncology therapy, targeting the CD19 surface antigen on B cells. BiTE® molecules help the immune system detect and target malignant cells by bringing T cells—a type of white blood cell capable of killing cells recognized as threats—into contact with cancer cells. By positioning T cells near cancer cells, they can...0 Kommentare 0 Anteile 2342 Ansichten
Mehr Artikel
DengYue Medicine (DengYueMed/Hong Kong Dengyue Pharmaceutical Limited), founded in 2019, is located in Hong Kong SAR. DengYue is licensed by the Department of Health of Hong Kong to take photos of pharmaceutical import and export wholesalers, specializing in the import and export of new and specialty drugs as well as isolated drugs in the field of major chronic diseases.
- 3 Beiträge
- 0 Fotos
- 0 Videos
- Male
- 08/09/2005
- anschliessend 0 people